Munir Ghesani
Chief Medical Officer & Director United Theranostics
Seminars
Thursday 23rd July 2026
Optimizing Radiopharmaceutical Dosing Within FDA Guidance: Strategies to Maximize Efficacy & Minimize Toxicity
1:30 pm
- Interpreting current FDA guidance on dose selection, escalation, and optimization for radioligand therapies
- Integrating pharmacokinetics, biodistribution, and safety data to refine patient-specific dosing strategies
- Applying regulatory best practices to design trials that balance therapeutic efficacy with minimization of off-target toxicity
Tuesday 21st July 2026
Designing a Radiopharmaceutical Clinical Trial: Key Considerations from the Start
2:00 pm
- Outlining the network of clinical experts who are involved from nuclear medical physicians to medical oncologists
- Key differences in a radiopharma trial
- Radiation safety considerations
- If clinical trials require a clinical sub study/assessment?
- Importance of onsite imaging
